These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2504023)

  • 1. The value of the sinusoidal tcPO2 pattern in the evaluation and management of cyanotic congenital heart disease with ductus dependent lesions.
    Seki S; Ikenoue T; Hokanishi H; Hayakawa K
    Acta Paediatr Jpn; 1989 Feb; 31(1):24-9. PubMed ID: 2504023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous oxygen monitoring. Its use in the treatment of outpatients with congenital heart disease.
    Gidding SS; Rosenthal A; Moorehead C
    Am J Dis Child; 1985 Mar; 139(3):288-91. PubMed ID: 3976611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous PO2 monitoring in infants with cyanotic congenital heart disease treated with prostaglandin E1.
    Kimble KJ; Ariagno RL; Pitlick P
    Pediatr Cardiol; 1983; 4(2):87-9. PubMed ID: 6878077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive transcutaneous oxygen pressure diagnosis of reversed ductal shunts in cyanotic heart disease.
    Tateishi K; Yamanouchi I
    Pediatrics; 1980 Jul; 66(1):22-5. PubMed ID: 7402787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulse oximetry in cyanotic congenital heart disease.
    Gidding SS
    Am J Cardiol; 1992 Aug; 70(3):391-2. PubMed ID: 1632410
    [No Abstract]   [Full Text] [Related]  

  • 6. Noninvasive pulse oximetry in children with cyanotic congenital heart disease.
    Boxer RA; Gottesfeld I; Singh S; LaCorte MA; Parnell VA; Walker P
    Crit Care Med; 1987 Nov; 15(11):1062-4. PubMed ID: 3677750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturation with oxygen for ductal dependent congenital heart diseases before and after the prostaglandin therapy.
    Dinarević S; Maksić H; Haznadar M
    Bosn J Basic Med Sci; 2005 Feb; 5(1):14-8. PubMed ID: 15771597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial oxygen tension and response to oxygen breathing in differential diagnosis of congenital heart disease in infancy.
    Jones RW; Baumer JH; Joseph MC; Shinebourne EA
    Arch Dis Child; 1976 Sep; 51(9):667-673. PubMed ID: 999325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous dilator prostaglandins in congenital heart disease.
    Hammerman C; Aramburo MJ; Bui KC
    Pediatr Cardiol; 1987; 8(3):155-9. PubMed ID: 3324070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
    Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
    Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of congenital heart disease in tertiary care hospital.
    Shah GS; Singh MK; Pandey TR; Kalakheti BK; Bhandari GP
    Kathmandu Univ Med J (KUMJ); 2008; 6(1):33-6. PubMed ID: 18604112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous oxygen and carbon dioxide pressure monitoring to determine severity of limb ischemia and to predict surgical outcome.
    Lalka SG; Malone JM; Anderson GG; Hagaman RM; McIntyre KE; Bernhard VM
    J Vasc Surg; 1988 Apr; 7(4):507-14. PubMed ID: 3352067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive monitoring of carbon dioxide in infants and children with congenital heart disease: end-tidal versus transcutaneous techniques.
    Wilson J; Russo P; Russo J; Tobias JD
    J Intensive Care Med; 2005; 20(5):291-5. PubMed ID: 16145219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Episodic abnormalities in transcutaneous oxygen (TcPO2) recorded during neonatal intensive care.
    Horbar JD; Soll RF; McAuliffe TL; Clark T; Lucey JF
    J Perinatol; 1987; 7(1):2-7. PubMed ID: 3507537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG; Horsch S
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asplenia syndrome with atypical cardiac anomalies.
    Berman W; Yabek SM; Burstein J; Dillon T
    Pediatr Cardiol; 1982; 3(1):35-8. PubMed ID: 7155937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ductus arteriosus in neonatal cyanotic cardiopathies. Value of the recording of the cutaneous partial pressure of oxygen].
    de Geeter B; Heitz A; Eisenmann B; Willard D; Kieny R
    Arch Mal Coeur Vaiss; 1981 May; 74(5):573-8. PubMed ID: 6794478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilation of the ductus arteriosus by oral prostaglandin E1 derivative in cyanotic congenital heart diseases.
    Matsuura H; Saji T; Yamamoto S; Ishikita T; Aoki Y; Matsuo N
    Am Heart J; 1993 May; 125(5 Pt 1):1453-4. PubMed ID: 8480610
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of prostaglandins in neonatal cardiology].
    Dinarević S; Kurtagić S; Maksić H
    Med Arh; 2000; 54(5-6):279-82. PubMed ID: 11219904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right-to-left ductal shunt and transcutaneous PO2.
    de Geeter B; Messer J; Benoit M; Willard D
    Birth Defects Orig Artic Ser; 1979; 15(4):387-92. PubMed ID: 534722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.